antipsicóticos - resumo

2
Antipsychotic s (neuroleptics) The dopamine hypothesis of psychosis:  Psychotic symptoms result from ! dopamine neurotransmission Dopamine receptors: o D1-like: ! D1 and D5 ! Are post-synapt ic ! Stimulate adenylate cyclase and ! cAMP o  D2-like: ! D2, D3 and D4 ! Are both pre- and post-synaptic !  Inhibit a denylate cyclase and " cAMP Dopaminergic pathways: o  Mesolimbic / mesocortical : ! Concerned with mood and emotional stability ! Ventral tegmental area: Ventral striatum and the frontal cortex o Nigrostriatal: ! Concerned with movement ! Substantia nigra and the dorsal striatum Neuroleptics block D2 receptors: o Explains why they cause movement disorders as a side effect Clinical classification of neuroleptics : Typical: o Produce extrapyramidal symptoms (EPS) Atypical: o So-called because they have a low incidence of EPS o However, all apart from clozapine can cause EPS at high doses Chemical classification of neuroleptics: Typical: o  Phenothiazines: ! Propylamines (chlorpromazine): Sedation ++ Anticholinergic ++ EPS ++ ! Piperidines (thioridazine ): Sedation ++ Anticholinergic ++ EPS + Can cause torsade de pointes ! Piperazines (fluphenazine): Sedation + Anticholinergic + EPS +++ o  Thioxanthines (flupenthixole ): ! Sedation +  ! Anticholinergic + ! EPS ++ o  Butyrophenones (haloperidol ): ! Sedation - ! Anticholinergic - ! EPS +++ Atypical: o  “True”: !  Clozapine: Sedation ++ Anticholine rgic + EPS - o  “Apparent”: !  Sulpiride: Sedation + Anticholine rgic EPS + !  Risperidone: Sedation ++ Anticholine rgic + EPS + General effects of the neuroleptics: Early (hours): o  Desired: ! Sedation (histamine / #-receptor blockade) ! Tranquilisatio n (dopamine blockade) o  Unwanted: ! Acute dystonic reactions Medium (days–weeks ): o  Desired: ! Suppression of: Delusions Disordered thinking Hallucinations o  Unwanted: ! Akathisia ! Parkinsonism Late (months–y ears): o  Desired: ! Prevention of relapse o  Unwanted: !  Tardive dyskinesia Any time: o  Neuroleptic malignant syndrome Chlorpromazine: Indications: o  Psychotic disorders (e.g. schizophrenia / mania) o Labyrinthine disorders / vertigo  

Upload: livia-zadra

Post on 17-Feb-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Antipsicóticos - Resumo

7/23/2019 Antipsicóticos - Resumo

http://slidepdf.com/reader/full/antipsicoticos-resumo 1/2

Antipsychotics (neuroleptics)

The dopamine hypothesis of psychosis:•   Psychotic symptoms result from ! dopamine neurotransmission• Dopamine receptors:

o D1-like:! D1 and D5

! Are post-synaptic! Stimulate adenylate cyclase and ! cAMP

o   D2-like:! D2, D3 and D4

! Are both pre- and post-synaptic!   Inhibit adenylate cyclase and " cAMP

• Dopaminergic pathways:o   Mesolimbic / mesocortical:

! Concerned with mood and emotional stability! Ventral tegmental area:

• Ventral striatum and the frontal cortexo Nigrostriatal:

! Concerned with movement! Substantia nigra and the dorsal striatum

• Neuroleptics block D2 receptors:o Explains why they cause movement disorders as a side effect

Clinical classification of neuroleptics:• Typical:

o Produce extrapyramidal symptoms (EPS)• Atypical:

o So-called because they have a low incidence of EPSo However, all apart from clozapine can cause EPS at high doses

Chemical classification of neuroleptics:• Typical:

o   Phenothiazines:! Propylamines (chlorpromazine):

• Sedation ++• Anticholinergic ++• EPS ++

! Piperidines (thioridazine):• Sedation ++• Anticholinergic ++• EPS +• Can cause torsade de pointes

! Piperazines (fluphenazine):• Sedation +• Anticholinergic +• EPS +++

o   Thioxanthines (flupenthixole):! Sedation +

 

! Anticholinergic +! EPS ++

o   Butyrophenones (haloperidol):! Sedation -! Anticholinergic -! EPS +++

• Atypical:o  “True”:

!   Clozapine:• Sedation ++• Anticholinergic +• EPS -

o  “Apparent”:!   Sulpiride:

• Sedation +• Anticholinergic –• EPS +

!   Risperidone:• Sedation ++• Anticholinergic +• EPS +

General effects of the neuroleptics:• Early (hours):

o   Desired:! Sedation (histamine / #-receptor blockade)! Tranquilisation (dopamine blockade)

o   Unwanted:! Acute dystonic reactions

• Medium (days–weeks):o   Desired:

! Suppression of:• Delusions• Disordered thinking• Hallucinations

o   Unwanted:! Akathisia! Parkinsonism

• Late (months–years):o   Desired:

! Prevention of relapseo   Unwanted:

!  Tardive dyskinesia• Any time:

o   Neuroleptic malignant syndromeChlorpromazine:

• Indications:o   Psychotic disorders (e.g. schizophrenia / mania)o Labyrinthine disorders / vertigo

 

Page 2: Antipsicóticos - Resumo

7/23/2019 Antipsicóticos - Resumo

http://slidepdf.com/reader/full/antipsicoticos-resumo 2/2

o Nausea / vomitingo   Chronic hiccups

• Adverse effects:o   Common:

!   Sedation!   Anticholinergic effects:

• Blurred vision• Dry mouth• Postural hypotension• Constipation• Urinary retention

!   Extrapyramidal effects:• Acute dystonia• Akathisia• Parkinsonism• Tardive dyskinesia

!   Hyperprolactinaemia:• Amenorrhoea• Galactorrhoea• Impotence

o Uncommon:! Neuroleptic malignant syndrome! Agranulocytosis!   Cholestatic  jaundice

Interactions:o ACE inhibitors:

! Can cause severe hypotension

Haloperidol:• Indications:

o   Psychosiso   Motor tics

• Adverse effects:o Common:

!   Extrapyramidal effects:• Acute dystonia• Akathisia• Parkinsonism

!   Postural hypotensiono Uncommon:

! Convulsions! Neuroleptic malignant syndrome! Tardive dyskinesia! Weight loss

• Interactions:o Amiodarone:

!   ! risk of ventricular arrhythmiaso Carbamazepine:

!   " plasma levels of haloperidol (metabolism accelerated)

 

o Fluoxetine:!   ! plasma levels of haloperidol

Clozapine:• Regarded by many as the only “true” atypical neuroleptic:

o   EPS is not evident even at high doseso   Effective in patients refractory to other neurolepticso Can treat the negative symptoms of schizophrenia

• Mechanism of action:o   Blocks D4 and 5-HT2 receptorso Weak blockade of striatal D2 receptors

• Adverse effects:o   Agranulocytosis (requires regular blood monitoring)o Myocarditis / cardiomyopathyo Ileus

• Contraindications:o Severe cardiac disorderso History of neutropenia / agranulocytosis

• Interactions:o Avoid concomitant use with drugs that have a high risk of

causing agranulocytosis (e.g. carbimazole)